Back to Home

Healthcare Affordability & Cost Trends

Expert articles and analysis related to healthcare affordability & cost trends.

199 articlesLast 30 Days

AI Summary — Last 30 Days

In the past 30 days, the Trump administration’s CMS has initiated a major structural shift with the rollout of the Transforming Episode Accountability Model (TEAM), marking a return to mandatory bundled payments and signaling tighter hospital accountability for surgical episode costs and outcomes. These changes, anchored in the FY 2026 IPPS Final Rule, impose differentiated episode discounts (e.g., 2% for LEJR, SHFFT, spinal fusion; 1.5% for CABG, major bowel) and will reshape financial risk profiles for providers, requiring health systems and ACOs to recalibrate cost management and readiness plans in alignment with new episode-based incentives and composite quality scoring methodologies. The renewed value-based policy emphasis—alongside ongoing debate about program cost-effectiveness and implementation complexity—underlines heightened strategic tension between payers, providers, and health systems as value-based care adoption re-accelerates. See Techy Surgeon’s TEAM Bundle analysis and RACMonitor's overview for further

Related Articles

100ALN

Op-Ed—American healthcare has a pricing problem

Op-Ed—American healthcare has a pricing problem  Fierce Healthcare

fiercehealthcare.comMar 6, 2026
100ALN

Health Care Affordability: A Tale of Two Populations, or Twenty Years Since

Health Care Affordability: A Tale of Two Populations, or Twenty Years Since  American Enterprise Institute - AEI

aei.orgMar 5, 2026
100ALN

American health care policy reform: Why we need a bipartisan commission

America is ready for an honest conversation about health care policy before more people suffer and we go broke waiting for it to happen. Fully one-third of Americans report that in the past 12 months ...

kevinmd.comMar 4, 2026
90ALN

STAT+: Novo Nordisk’s Wegovy and Ozempic shots could be made for as little as $3 a month, analysis finds

Generic versions of Novo Nordisk’s Wegovy and Ozempic medications could be mass produced for about $3 per person a month, according to a new analysis.

statnews.comMar 6, 2026
90ALN

Federal push for site-neutral payments could accelerate reshaping of sites of care

Federal push for site-neutral payments could accelerate reshaping of sites of care  Chartis

chartis.comMar 5, 2026
90ALN

Chronic condition patients drive most of healthcare use: Vizient

Chronic condition patients drive most of healthcare use: Vizient  Modern Healthcare

modernhealthcare.comMar 5, 2026
90ALN

MaineHealth protests bill to cap hospital procedure costs

MaineHealth protests bill to cap hospital procedure costs  Becker's Hospital Review

beckershospitalreview.comMar 5, 2026
90ALN

Hospital drug prices vary widely, advocacy tool shows

Hospital drug prices vary widely, advocacy tool shows  Becker's Hospital Review

beckershospitalreview.comMar 5, 2026
90ALN

Optum Rx, Caremark making ‘significant progress’ in settlement talks with FTC

It’s looking increasingly likely that the UnitedHealth and CVS drug middlemen will also make peace with federal regulators, after Cigna agreed to a sweeping settlement in the insulin lawsuit last mont...

healthcaredive.comMar 5, 2026
90ALN

Novo Nordisk, Eli Lilly tighten 340B oversight as providers fume

Novo Nordisk, Eli Lilly tighten 340B oversight as providers fume  Modern Healthcare

modernhealthcare.comMar 5, 2026